Neurodevelopmental DisorderLEGONCT06641583
Efficacy of LEGO Therapy for Adolescent With Level 1 Autism
A study testing LEGO in people with Neurodevelopmental Disorder, run by Antonio Narzisi at 1 site in Italy.
Trial summary
The goal of this clinical trial is to learn if LEGO therapy can enhance social skills in children aged 10-14 diagnosed with high-functioning Autism Spectrum Disorder. The main questions it aims to answer are: Does LEGO therapy improve social communication and interaction skills in children with Autism Spectrum… Read more about this study
- Who is it for?
- Ages 10 to 14 years
- Conditions the study is for
- Neurodevelopmental Disorder
- What is being tested?
- LEGO
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteItaly
- Study dates
- 20 Sep 2024to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 14 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- age between 10 and 14 years;
- clinical diagnosis of Autism Spectrum Disorder according to ICD-10 (WHO, 1992);
- intellectual level in the normal range (IQ\>85);
- self-motivation to participate in the treatment both as regards the adolescent and the family;
- availability of caregiver support the participant during the programme;
- consent of the parents and the adolescent to participate in all evaluations and to be recorded during treatment sessions.
Who cannot join
- presence of a concomitant major psychiatric disorder (e.g., schizophrenia bipolar disorder);
- presence of oppositional/aggressive behaviour (outside the family context) family context);
- presence of genetic syndromes associated with autism spectrum disorder.
Trial locations and contacts
1 site in 1 country.
About this study
The goal of this clinical trial is to learn if LEGO therapy can enhance social skills in children aged 10-14 diagnosed with high-functioning Autism Spectrum Disorder. The main questions it aims to answer are:
Does LEGO therapy improve social communication and interaction skills in children with Autism Spectrum Disorder? Do children show behavioral improvements in social skills after participating in LEGO therapy? Researchers will compare children receiving LEGO therapy to a control group (who will not receive LEGO therapy but continue their usual treatments) to see if LEGO therapy leads to greater improvements in social skills.
Read more
Participants will:
Complete behavioral tasks, including a LEGO construction test, at the beginning (T0) and after 3 months (T1).
Attend weekly LEGO therapy sessions for 90 minutes, over the course of 3 months (12 sessions).
Complete questionnaires about social behaviors, both parents and children, at T0 and T1.
Read the detailed description
The study aims to involve children with Autism in a social skills enhancement program called LEGO therapy. The program will consist of 12 sessions (over 3 months), held once a week for 90 minutes. These sessions will take place at the IRCCS Fondazione Stella Maris in Calambrone (Pisa). Before the program starts (T0) and after it ends (T1, 3 months later), both parents and their children will be asked to complete some questionnaires designed to investigate potential changes in certain behavioral variables before and after the LEGO Therapy intervention. Additionally, at both T0 and T1, children will also be assessed through a LEGO construction task.
LEGO Therapy Intervention The LEGO therapy sessions will be conducted in a group setting. The group will consist of three children of the same age, all diagnosed with high-functioning Autism Spectrum Disorder. The group will be supervised by staff specialized in neurodevelopmental disorders. Participation is voluntary, and partecipants may withdraw from the study at any time, for any reason, without penalty. All collected data will remain anonymous and analyzed in aggregate form. The questionnaires are not designed to collect personal information about parents or their children. The study does not intend to evaluate other aspects beyond those specified, and no incidental findings (e.g., clinical or diagnostic) are expected. The collected data will be stored on a private server and only accessible to the study supervisors (i.e., not provided to third parties) for five years. The results will be used for publications and presentations in academic and scientific settings. Participation in the study poses no specific risks, and children can pause and resume the questionnaire at any time. If partecipants have any questions or concerns about the nature of this research, please contact the lead researcher Antonio Narzisi at IRCCS Fondazione Stella Maris, 050886308, antonio.narzisi@fsm.unipi.it.
What are the characteristics of this study?
This is an interventional study involving 64 subjects with Autism Spectrum Disorder (both male and female), aged 10 to 14. The children will be consecutively recruited either from natural admissions to the IRCCS Fondazione Stella Maris - Operational Unit 2 of Child and Adolescent Psychiatry and Psychopharmacology or through outpatient services. The study will last 6 months, during which time the investigators plan to engage participants. Specifically, this is an open-label randomized study, meaning that both the experimenter and the participant will know the type of treatment being studied. The investigators recognize that open-label studies can introduce bias due to participants and caregivers being aware of the treatment. However, the investigators are implementing several strategies to mitigate these biases:
Blinding of Assessors: The outcome assessors will be unaware of the treatment group to which the participants have been assigned, reducing the risk of bias in outcome assessments.
Use of Objective Measures: The investigators will include objective and standardized measures to evaluate outcomes, in addition to subjective assessments from participants and caregivers.
Data Analysis: The investigators will perform rigorous statistical analyses to control for and identify potential confounding effects related to treatment awareness.
Even though LEGO therapy is well-structured and has demonstrated efficacy in the United States, the investigators cannot assume that the results will automatically translate to the Italian context. Cultural, social, and systemic differences may influence treatment effectiveness. Therefore, a local evaluation of effectiveness is essential to:
- Validate the Intervention: Confirm that the therapy produces the same benefits in the new cultural context.
- Adapt the Protocol: Identify and make any necessary adjustments to optimize the intervention for the Italian population.
- Generate Local Evidence: Provide relevant data for healthcare professionals and policymakers in Italy, supporting the adoption of therapy based on local evidence.
In summary, assessing the effectiveness and cultural adaptability of LEGO therapy in the Italian context is crucial to ensure the treatment is not only applicable but also effective for the new target population. The investigators are aware of the challenges associated with bias in open-label studies and are implementing strategies to mitigate them while ensuring robust and reliable results.
What exams, tests, and procedures are included in the study? If parents decide to allow their child to participate in the study, please note that it involves the administration of certain questionnaires and semi-structured interviews to both parents and their children, as part of routine clinical practice. Specifically, parents will be asked to complete some questionnaires at baseline (T0) and at T1 (after 3 months), with an estimated completion time of around 60 minutes.
Additionally, all children will undergo a behavioral task at both T0 and T1, where they will be engaged in building a LEGO composition on their own and in collaboration with an examiner. The tasks will be recorded and will last no longer than 10 minutes.
After the T0 evaluation, the children will be randomized into two groups: experimental (LEGO therapy) and control (not receiving LEGO therapy). The experimental group will attend weekly LEGO therapy sessions at IRCCS Stella Maris, lasting 90 minutes, for three months (12 sessions). The control group will continue their regular therapies in their local areas and will not receive LEGO therapy. As stated earlier, at the end of the three-month intervention, both experimental and control groups will undergo an outcome assessment, which will take place at IRCCS Stella Maris.
- Conditions
- Neurodevelopmental Disorder
- Being tested
- LEGO, Controllo
- Keywords
- Autism Spectrum Disorder, ADHD
- Medical subject headings
- Neurodevelopmental Disorders, Autism Spectrum Disorder, Attention Deficit Disorder with Hyperactivity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
LEGOBehavioural
The LEGO Therapy intervention in this clinical trial is designed to enhance social skills in children with high-functioning Autism Spectrum Disorder (ASD). The intervention involves the following components:
Group Sessions: The therapy will be conducted in small groups of three children of the same age (10-14 years) with a diagnosis of high-functioning ASD. The sessions are designed to foster collaboration and social interaction between the participants.
Duration: The intervention will last for 3 months, consisting of 12 sessions, with each session lasting 90 minutes. Sessions will take place once a week at the IRCCS Fondazione Stella Maris.
Supervision: The groups will be supervised by trained professionals specializing in neurodevelopmental disorders, ensuring that the therapy is structured and supportive of each child\'s individual needs.
Therapy Structure: During the sessions, children will engage in LEGO-based tasks, where they collaborate to build LEGO models.
ControlloOther
This group will also consist of children aged 10-14 diagnosed with high-functioning ASD. However, these children will not receive LEGO therapy. Instead, they will continue their usual treatments in their local settings without participating in the LEGO therapy sessions. This group\'s outcomes will be compared with the experimental group to assess the effectiveness of LEGO therapy.
| Study group | Role | What they receive |
|---|---|---|
| Exprimental | Experimental | Experimental Group: This group will consist of children aged 10-14 diagnosed with high-functioning Autism Spectrum Disorder (ASD). These children will participate in LEGO therapy sessions once a week for 90 minutes over the course of 3 months (12 sessions total). The goal is to evaluate how LEGO therapy influences their social skills and behavior. Receives: Behavioral: LEGO |
| Control | Active comparator | Control Group: This group will also consist of children aged 10-14 diagnosed with high-functioning ASD. However, these children will not receive LEGO therapy. Instead, they will continue their usual treatments in their local settings without participating in the LEGO therapy sessions. This group's outcomes will be compared with the experimental group to assess the effectiveness of LEGO therapy. Receives: Other: Controllo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Social Skills
- Social Skills Improvement System RatingScales (SSiS) (Gresham \& Elliott, 2008). The Social Skills Improvement System-Rating Scales (SSIS-RS; Gresham \& Elliott, 2008) is a multi-rater (teacher, parent/caregiver, and student) series of rating scales that documents the frequency of social skills and competing problem behaviors. It is a revision of the Social Skills Rating System (SSRS; Gresham \& Elliott, 1990). The SSIS-RS assess three domains of social skills, problem behaviors, and academic competence. All forms include common social skills in multiple subdomains: communication, cooperation, assertion, responsibility, empathy, engagement, and self-control. The subscales are grouped beneath Problem Behavior and Social Skills domains. Higher scores mean a better.
Measured: From enrollment (T0) to the end of treatment at 12 weeks
Secondary outcomes (1)
Autistic symtoms
- ADOS-BOSCC (Lord Group). The brief observation of social communication change (BOSCC) was specifically developed to measure change of core autistic symptoms, for example, for use as outcome measure in early intervention trials. Higher scores mean a worse outcome
Measured: From enrollment (T0) to the end of treatment at 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Oct 2024
- Study start20 Sep 2024
- Primary completion31 Dec 2025
- Study completion31 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Neurodevelopmental DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Antonio Narzisi
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Antonio Narzisi, IRCCS Fondazione Stella Maris
- Investigators
- Giovanni Cioni, Neurolgy, Study director, IRCCS Fondazione Stella MarisAntonio Narzisi, Psychology, Principal investigator, IRCCS Fondazione Stella Maris
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06641583
- Sponsor's protocol ID
- LEGO 126/2024
- Acronym
- LEGO
- Status last verified
- Mar 2026
- First submitted
- 9 Oct 2024
- Last updated
- 1 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: all IPD collected throughout the trial
Study at a glance
From the registry record, last updated by the sponsor on 1 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of LEGO Therapy for Adolescent With Level 1 Autism
- ClinicalTrials.gov ID
- NCT06641583
- Acronym / sponsor ID
- LEGO / LEGO 126/2024
- Conditions
- Neurodevelopmental Disorder
- Keywords
- Autism Spectrum Disorder, ADHD
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Antonio NarzisiUniversity, hospital or other
- Study start
- 20 Sep 2024 (actual)
- Primary completion
- 31 Dec 2025 (actual)
- Study completion
- 31 Dec 2025 (actual)
- First posted
- 15 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if LEGO therapy can enhance social skills in children aged 10-14 diagnosed with high-functioning Autism Spectrum Disorder. The main questions it aims to answer are:
Does LEGO therapy improve social communication and interaction skills in children with Autism Spectrum Disorder? Do children show behavioral improvements in social skills after participating in LEGO therapy? Researchers will compare children receiving LEGO therapy to a control group (who will not receive LEGO therapy but continue their usual treatments) to see if LEGO therapy leads to greater improvements in social skills.
Participants will:
Complete behavioral tasks, including a LEGO construction test, at the beginning (T0) and after 3 months (T1).
Attend weekly LEGO therapy sessions for 90 minutes, over the course of 3 months (12 sessions).
Complete questionnaires about social behaviors, both parents and children, at T0 and T1.
Detailed description
The study aims to involve children with Autism in a social skills enhancement program called LEGO therapy. The program will consist of 12 sessions (over 3 months), held once a week for 90 minutes. These sessions will take place at the IRCCS Fondazione Stella Maris in Calambrone (Pisa). Before the program starts (T0) and after it ends (T1, 3 months later), both parents and their children will be asked to complete some questionnaires designed to investigate potential changes in certain behavioral variables before and after the LEGO Therapy intervention. Additionally, at both T0 and T1, children will also be assessed through a LEGO construction task.
LEGO Therapy Intervention The LEGO therapy sessions will be conducted in a group setting. The group will consist of three children of the same age, all diagnosed with high-functioning Autism Spectrum Disorder. The group will be supervised by staff specialized in neurodevelopmental disorders. Participation is voluntary, and partecipants may withdraw from the study at any time, for any reason, without penalty. All collected data will remain anonymous and analyzed in aggregate form. The questionnaires are not designed to collect personal information about parents or their children. The study does not intend to evaluate other aspects beyond those specified, and no incidental findings (e.g., clinical or diagnostic) are expected. The collected data will be stored on a private server and only accessible to the study supervisors (i.e., not provided to third parties) for five years. The results will be used for publications and presentations in academic and scientific settings. Participation in the study poses no specific risks, and children can pause and resume the questionnaire at any time. If partecipants have any questions or concerns about the nature of this research, please contact the lead researcher Antonio Narzisi at IRCCS Fondazione Stella Maris, 050886308, antonio.narzisi@fsm.unipi.it.
What are the characteristics of this study?
This is an interventional study involving 64 subjects with Autism Spectrum Disorder (both male and female), aged 10 to 14. The children will be consecutively recruited either from natural admissions to the IRCCS Fondazione Stella Maris - Operational Unit 2 of Child and Adolescent Psychiatry and Psychopharmacology or through outpatient services. The study will last 6 months, during which time the investigators plan to engage participants. Specifically, this is an open-label randomized study, meaning that both the experimenter and the participant will know the type of treatment being studied. The investigators recognize that open-label studies can introduce bias due to participants and caregivers being aware of the treatment. However, the investigators are implementing several strategies to mitigate these biases:
Blinding of Assessors: The outcome assessors will be unaware of the treatment group to which the participants have been assigned, reducing the risk of bias in outcome assessments.
Use of Objective Measures: The investigators will include objective and standardized measures to evaluate outcomes, in addition to subjective assessments from participants and caregivers.
Data Analysis: The investigators will perform rigorous statistical analyses to control for and identify potential confounding effects related to treatment awareness.
Even though LEGO therapy is well-structured and has demonstrated efficacy in the United States, the investigators cannot assume that the results will automatically translate to the Italian context. Cultural, social, and systemic differences may influence treatment effectiveness. Therefore, a local evaluation of effectiveness is essential to:
- Validate the Intervention: Confirm that the therapy produces the same benefits in the new cultural context.
- Adapt the Protocol: Identify and make any necessary adjustments to optimize the intervention for the Italian population.
- Generate Local Evidence: Provide relevant data for healthcare professionals and policymakers in Italy, supporting the adoption of therapy based on local evidence.
In summary, assessing the effectiveness and cultural adaptability of LEGO therapy in the Italian context is crucial to ensure the treatment is not only applicable but also effective for the new target population. The investigators are aware of the challenges associated with bias in open-label studies and are implementing strategies to mitigate them while ensuring robust and reliable results.
What exams, tests, and procedures are included in the study? If parents decide to allow their child to participate in the study, please note that it involves the administration of certain questionnaires and semi-structured interviews to both parents and their children, as part of routine clinical practice. Specifically, parents will be asked to complete some questionnaires at baseline (T0) and at T1 (after 3 months), with an estimated completion time of around 60 minutes.
Additionally, all children will undergo a behavioral task at both T0 and T1, where they will be engaged in building a LEGO composition on their own and in collaboration with an examiner. The tasks will be recorded and will last no longer than 10 minutes.
After the T0 evaluation, the children will be randomized into two groups: experimental (LEGO therapy) and control (not receiving LEGO therapy). The experimental group will attend weekly LEGO therapy sessions at IRCCS Stella Maris, lasting 90 minutes, for three months (12 sessions). The control group will continue their regular therapies in their local areas and will not receive LEGO therapy. As stated earlier, at the end of the three-month intervention, both experimental and control groups will undergo an outcome assessment, which will take place at IRCCS Stella Maris.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Exprimental | Experimental | Behavioral: LEGOExperimental Group: This group will consist of children aged 10-14 diagnosed with high-functioning Autism Spectrum Disorder (ASD). These children will participate in LEGO therapy sessions once a week for 90 minutes over the course of 3 months (12 sessions total). The goal is to evaluate how LEGO therapy influences their social skills and behavior. |
| Control | Active comparator | Other: ControlloControl Group: This group will also consist of children aged 10-14 diagnosed with high-functioning ASD. However, these children will not receive LEGO therapy. Instead, they will continue their usual treatments in their local settings without participating in the LEGO therapy sessions. This group's outcomes will be compared with the experimental group to assess the effectiveness of LEGO therapy. |
Who may qualify
- Ages
- 10 to 14 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (6 listed)
- age between 10 and 14 years;
- clinical diagnosis of Autism Spectrum Disorder according to ICD-10 (WHO, 1992);
- intellectual level in the normal range (IQ\>85);
- self-motivation to participate in the treatment both as regards the adolescent and the family;
- availability of caregiver support the participant during the programme;
Key exclusion criteria (3 listed)
- presence of a concomitant major psychiatric disorder (e.g., schizophrenia bipolar disorder);
- presence of oppositional/aggressive behaviour (outside the family context) family context);
- presence of genetic syndromes associated with autism spectrum disorder.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| LEGOThe LEGO Therapy intervention in this clinical trial is designed to enhance social skills in children with high-functioning Autism Spectrum Disorder (ASD). The intervention involves the following components: Group Sessions: The therapy will be conducted in small groups of three children of the same age (10-14 years) with a diagnosis of high-functioning ASD. The sessions are designed to foster collaboration and social interaction between the participants. Duration: The intervention will last for 3 months, consisting of 12 sessions, with each session lasting 90 minutes. Sessions will take place once a week at the IRCCS Fondazione Stella Maris. Supervision: The groups will be supervised by trained professionals specializing in neurodevelopmental disorders, ensuring that the therapy is structured and supportive of each child\'s individual needs. Therapy Structure: During the sessions, children will engage in LEGO-based tasks, where they collaborate to build LEGO models. | Behavioural | Exprimental |
| ControlloThis group will also consist of children aged 10-14 diagnosed with high-functioning ASD. However, these children will not receive LEGO therapy. Instead, they will continue their usual treatments in their local settings without participating in the LEGO therapy sessions. This group\'s outcomes will be compared with the experimental group to assess the effectiveness of LEGO therapy. | Other | Control |
Primary outcome
Social Skills
Time frame: From enrollment (T0) to the end of treatment at 12 weeks
1. Social Skills Improvement System RatingScales (SSiS) (Gresham \& Elliott, 2008). The Social Skills Improvement System-Rating Scales (SSIS-RS; Gresham \& Elliott, 2008) is a multi-rater (teacher, parent/caregiver, and student) series of rating scales that documents the frequency of social skills and competing problem behaviors. It is a revision of the Social Skills Rating System (SSRS; Gresham \& Elliott, 1990). The SSIS-RS assess three domains of social skills, problem behaviors, and academic competence. All forms include common social skills in multiple subdomains: communication, cooperation, assertion, responsibility, empathy, engagement, and self-control. The subscales are grouped beneath Problem Behavior and Social Skills domains. Higher scores mean a better.
1 secondary outcome
Autistic symtoms
Time frame: From enrollment (T0) to the end of treatment at 12 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Apr 2026.
- Individual participant dataSharing planned: Yes. all IPD collected throughout the trial
Related trials for Neurodevelopmental Disorder
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
RecruitingPhase 1
Cannabidiol (CBD) in Adults With ASD
Autism Spectrum Disorder
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingObservational study
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Disruptive Behavior Disorders, Conduct Disorder
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Giovanni Cioni, Neurolgy study director
IRCCS Fondazione Stella Maris
Antonio Narzisi, Psychology principal investigator
IRCCS Fondazione Stella Maris
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing LEGO in people with Neurodevelopmental Disorder, run by Antonio Narzisi at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Social Skills (time frame: From enrollment (T0) to the end of treatment at 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2026.